title: The cardiovascular risks of etoricoxib (Arcoxia).
authors.forename: Larry D
authors.initials: LD
authors.lastname: Sasich
authors.forename: Mohammed A
authors.initials: MA
authors.lastname: Barasain
authors.forename: Mohammed A
authors.initials: MA
authors.lastname: Al Kudsi
mesh_terms: D002318:Cardiovascular Diseases / Q000139:chemically induced*; D016861:Cyclooxygenase Inhibitors / Q000009:adverse effects*; D017277:Drug Approval; D000077613:Etoricoxib; D006801:Humans; D011725:Pyridines / Q000009:adverse effects*; D012529:Saudi Arabia; D013450:Sulfones / Q000009:adverse effects*; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D016861:Cyclooxygenase Inhibitors; D011725:Pyridines; D013450:Sulfones; D000077613:Etoricoxib